EQRx Investors

21 investors on Angel Roster list EQRx in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, Switzerland and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name EQRx can appear together.

Investors listed
21
With verified email
52%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 EQRx investors

The most complete profiles first. Showing 21 of 21.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Krishna YeshwantVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsHospitalsE-commerce

    Portfolio: Pixie, Dialpad, Science 37, Synack and 90 more

    Verified email available

  • Michael PelliniVerified

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareHospitalsGeneticsWellness

    Portfolio: Miroculus, Auris Health, Dialpad, XOKind and 32 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Karim FarisVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareTelecommunicationsE-commerceConsumer Goods

    Portfolio: Pixie, Dialpad, Science 37, Synack and 87 more

    Verified email available

  • Marcy MarshallVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Inogen, Cardiac Dimensions, Aira, Strata Oncology and 42 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Steve Kafka

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareHospitalsGeneticsWellness

    Portfolio: Miroculus, Auris Health, Dialpad, XOKind and 31 more

    Contact details available

  • Thomas Lips

    Venture Capital, Private Equity Firm, Investor · Switzerland

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more

    Contact details available

  • Jorge CondeVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BSeries APaymentsCybersecurityWomen FoundedEnterprise Software

    Portfolio: Tmunity Therapeutics, Eco, Vicinitas Therapeutics, EQRx and 2 more

    Verified email available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Dan Kidle

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Inogen, Cardiac Dimensions, Aira, Strata Oncology and 42 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Tim Petersen

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Inogen, Cardiac Dimensions, Aira, Strata Oncology and 42 more

    Contact details available

Frequently asked questions

How many EQRx investors are on Angel Roster?

Angel Roster lists 21 EQRx investors. 11 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), Private Equity Firms (10) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do EQRx investors invest in?

Among those that list a stage, the most common are Series B (8), Seed (4) and Pre-Seed (2).

Where are EQRx investors based?

Most are based in the United States (19), Switzerland (1) and the United Kingdom (1).

Which companies have EQRx investors backed?

The most-backed portfolio companies among them are Insitro (14), Verve Therapeutics (14), Vividion Therapeutics (13), Codiak Biosciences (12) and Maze Therapeutics (12).

How do I contact EQRx investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.